logo

Last Update

This profile was last updated on 1/1/2015 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Richard Guarino?

Richard A. Guarino

President

Oxford Pharmaceutical Services Inc

HQ Phone:  (973) 256-0600

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Background Information

Employment History

Editor

Informa Healthcare's Fourth Edition of New Drug Approval Process


Director of Clinical Research

Sandoz Inc


Affiliations

Food and Drug Administration

Liaison


Drug Information Association

Member


The Columbus Foundation

Member


Lupus Erythematosus Foundation

Member


Cystic Fibrosis Foundation

Member


Association of Clinical Research Professionals

Member


Education

M.D.

Oxford


Web References(20 Total References)


Press Release | Oxfordpharm.com

www.oxfordpharm.com [cached]

Questions or requests for prescribing information on Marplan® should be addressed to Dr. Richard Guarino - telephone number 973-256-0600, fax number 973-837-0572, e-mail admin@oxfordpharm.com.
Marplan®, a monoamine oxidase (MAO) inhibitor, is indicated as a second-line treatment for depression. "Marplan® is an important option for patients who are unresponsive to other antidepressants such as: SSRIs or traditional antidepressants like amitriptyline. Marplan® has shown significant efficacy in treating depression, and, for certain patients, may offer relief from depression that they otherwise might not be able to achieve," said Richard A. Guarino, M.D., President of Oxford. "We're delighted to be able to offer this medication for sale once again," said Guarino.


Marplan Press Release

www.oxfordpharm.com [cached]

Richard A. Guarino, M.D.
Oxford Pharmaceutical Services Inc. (973) 256-0600 OXFORD PHARMACEUTICAL SERVICES ACQUIRES MARPLAN® (isocarboxazid) FROM HOFFMANN-LA ROCHE Nutley, NJ and Clifton, NJ – October, 1998 – Hoffmann-La Roche Inc. and Oxford Pharmaceutical Services Inc., announced today that Oxford is acquiring ownership of the NDA for the antidepressant product Marplan ® (isocarboxazid) from Roche. Oxford will assume sales, marketing and distribution of Marplan ® November 13, 1998. Orders for Marplan ® should be directed to Oxford Pharmaceutical Services, Inc., 1585 US Highway 46 West, Totowa, NJ 07512. Questions or requests for prescribing information on Marplan ® should be addressed to Dr. Richard Guarino - telephone number 973-256-0600, fax number 973-837-0572, e-mail admin@oxfordpharm.com. Marplan®, a monoamine oxidase (MAO) inhibitor, is indicated as a second-line treatment for depression. "Marplan ® is an important option for patients who are unresponsive to other antidepressants such as: SSRIs or traditional antidepressants like amitriptyline. Marplan ® has shown significant efficacy in treating depression, and, for certain patients, may offer relief from depression that they otherwise might not be able to achieve," said Richard A. Guarino, M.D., President of Oxford. "We’re delighted to be able to offer this medication for sale once again," said Guarino.


Information for Healthcare Professionals | Oxfordpharm.com

www.oxfordpharm.com [cached]

For more information on Marplan, please call Dr. Richard Guarino at 973-256-0600 or email admin@oxfordpharm.com.


Marplan - Patient Information

www.oxfordpharm.com [cached]

For more information on Marplan, please call Dr. Richard Guarino at 973-256-0600 or email guarino@oxfordpharm.com.


www.hum-molgen.org

Richard A. Guarino, MD; President, Oxford Pharmaceutical Resources, Inc.
Dr. Richard A. Guarino is President of Oxford Pharmaceutical Resources, Inc., a Consulting Clinical and Regulatory Organization specializing in the planning, implementing and submitting INDs, NDAs, in the CTDs format. Dr, Guarino has 35 years of experience in new drug applications, marketing launches, pharmaceutical and product advertising, and FDA Liaison. He was formerly the President and CEO of Oxford Research International Corp. one of the largest CRO's in the United States. Besides serving as an adjunct professor at Fairleigh Dickinson University, he was a former Director of Clinical Research at Sandoz Pharmaceutical Inc, (Novartis) and held the position of Vice President/Medical Director at Revlon Healthcare Group. He has been acclaimed for his book, New Drug Approval Process, now in its 5th edition. It is the first book ever written to guide and recommend ways to expedite the new drug approval process while following all the requirements of the US Code of Federal Regulations, EU Directives and ICH Guidelines. Dr. Guarino is a member of many professional societies and associations including the New Jersey and New York Academies of Medicine, The Royal Society of Medicine, the Columbus Citizens Foundation, the Presidential Advisory Cabinet at Fairleigh Dickinson University, the Lupus Erythematosus Foundation, the Cystic Fibrosis Foundation and the Sovereign Military Hospitaller Order of Saint John of Jerusalem of Rhodes and of Malta American Association, USA Drug Information Association (DIA), Association of Clinical Research Professionals (ACRP), and Academy of Pharmaceutical Physicians and Investigators (APPI).


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory